Viviana Gradinaru

Dr. Gradinaru's lab recently developed capsids capable of crossing the blood-brain barrier, enabling noninvasive delivery of sensors and actuators to the CNS in transgenic and non-transgenic animals. With synergistic developments in actuators, systemic Adeno-associated viruses (AAVs) will allow researchers to modulate defined cell types and circuits across multiple deep-brain structures in a minimally invasive manner and test the behavioral effects of this modulation in animal models.

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Neuroscience

11 November 2028 San Diego, United States “Meet-the-Expert, Session 2: Machine-Learning Assisted Directed Evolution of Viral Vectors and Microbial Opsins for Minimally Invasive Neuroscience”

Neuroscience

13 November 2027 Chicago, United States “Meet-the-Expert, Session 2: Machine-Learning Assisted Directed Evolution of Viral Vectors and Microbial Opsins for Minimally Invasive Neuroscience”

Neuroscience

14 November 2026 Washington, United States “Meet-the-Expert, Session 2: Machine-Learning Assisted Directed Evolution of Viral Vectors and Microbial Opsins for Minimally Invasive Neuroscience”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →